Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial.
Tali Cukierman-YaffeChinthanie RamasundarahettigeJackie BoschUlagamadesan VenkatesanPublished in: Diabetes, obesity & metabolism (2024)
In this post hoc exploratory analysis, insulin glargine-mediated normoglycaemia but not omega 3 fatty acids reduced the hazard of substantive cognitive impairment in people with dysglycaemia and additional cardiovascular risk factors.